Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...

Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...

Collaboration Leverages Made Scientific's Industry Expertise and Workforce Development Initiative to Empower the Next Generation of Cell and Gene Therapy Professionals PRINCETON, N.J. and NEWARK, N.J.

SHANGHAI, March 19 (Reuters) - AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an ...

Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing autoimmune disease and ...

In cell therapy applications, commonly employed cell purification platforms for large-scale isolation of immune or stem cells separate cells based on a single cell surface antigen. Enrichment based on ...

Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.

Issued on behalf of Avaí Bio, Inc.Companies mentioned in this article: Avaí Bio (OTCQB: AVAI), FibroBiologics (NASDAQ: FBLG), Fate Therapeutics ...

As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.